AMRX
Price
$20.31
Change
+$0.24 (+1.20%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
7.14B
27 days until earnings call
Intraday BUY SELL Signals
ANIP
Price
$72.23
Change
-$0.73 (-1.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.72B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRX vs ANIP

AMRX vs ANIP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMRX vs. ANIP commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and ANIP is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
AMRX vs ANIP: Fundamental Ratings
AMRX
ANIP
OUTLOOK RATING
1..100
8835
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
738
SMR RATING
1..100
9948
PRICE GROWTH RATING
1..100
3670
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIP's Valuation (71) in the Pharmaceuticals Other industry is in the same range as AMRX (90) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (7) in the Pharmaceuticals Major industry is in the same range as ANIP (38) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Price Growth Rating (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for ANIP (70) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than ANIP’s over the last 12 months.

ANIP's P/E Growth Rating (98) in the Pharmaceuticals Other industry is in the same range as AMRX (100) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXANIP
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 8 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
73%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (AMRX: $20.07 vs. ANIP: $72.96)
Brand notoriety: AMRX and ANIP are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 149% vs. ANIP: 65%
Market capitalization -- AMRX: $7.14B vs. ANIP: $1.72B
AMRX [@Pharmaceuticals: Generic] is valued at $7.14B. ANIP’s [@Pharmaceuticals: Generic] market capitalization is $1.72B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green while ANIP’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ANIP’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMRX and ANIP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while ANIP’s TA Score has 3 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 5 bearish.
  • ANIP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than ANIP.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а +1.34% price change this week, while ANIP (@Pharmaceuticals: Generic) price change was -1.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.75%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

AMRX is expected to report earnings on Oct 29, 2026.

ANIP is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.75% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
AMRX
Daily Signal:
Gain/Loss:
ANIP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBIO8.130.21
+2.65%
Harvard Bioscience Inc.
TVAL41.99-0.02
-0.05%
T. Rowe Price Value ETF (TVAL)
AAON82.28-0.48
-0.58%
AAON
FVRR8.56-0.06
-0.70%
Fiverr International Ltd
MAZE26.65-0.53
-1.95%
Maze Therapeutics Inc

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with AMPH. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-0.35%
AMPH - AMRX
45%
Loosely correlated
-1.78%
VTRS - AMRX
43%
Loosely correlated
-1.47%
TEVA - AMRX
38%
Loosely correlated
-0.73%
ANIP - AMRX
38%
Loosely correlated
+0.43%
COLL - AMRX
35%
Loosely correlated
+0.09%
More

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+0.43%
AMRX - ANIP
38%
Loosely correlated
-0.35%
AMPH - ANIP
33%
Loosely correlated
-1.78%
SUPN - ANIP
33%
Poorly correlated
-2.00%
SNDL - ANIP
31%
Poorly correlated
-2.33%
PBH - ANIP
31%
Poorly correlated
-2.40%
More